Healing Patients Through Their Whole Journey The program offers stem cell transplants and other cellular
If you have a blood cancer or disorder, like leukemia, lymphoma, or myeloma, your doctor may have recommended a stem cell transplant. That would mean traveling to Nashville or Atlanta for treatment. But now the new Transplant and Cellular Therapy (TCT)
therapies that are designed to help the immune system fight cancer, like: • Chimeric antigen receptor T-cell (CAR-T) therapy • Immune effector cell therapy Filling a Critical Need for East Tennessee TCT center physicians will work closely with other local physicians who specialize in treating blood cancers to identify and refer patients who will benefit from these treatments. Even after the patients’ treatment programs end, the medical center’s care team will continue to collaborate with the patient’s referring primary physician. “Our goal is to maintain the patients’ continued well-being and assess the need for any future treatments,” said McCaul. The TCT center will fill a critical need for East Tennessee patients with blood disorders and cancers. Dealing with a diagnosis like this is an already stressful experience. Having the center in Knoxville will help relieve the stress of being away from home and loved ones, which goes a long way toward helping patients heal.
on the fourth floor of the medical center’s Cancer Institute, will include both inpatient and outpatient services. With expert physicians, nurses, registered dietitians, social workers, and many other behind- the-scenes professionals, patients will receive the highest level of care throughout their entire cancer treatment journey at the TCT center. Raj said, “It’s a very efficient and meaningful way to operate, with all the levels of care for the patient in the same place.” In addition to large, comfortable inpatient rooms, the TCT floor will also include a stem cell collection area. There will also be a cell processing lab where harvested stem cells are stored in liquid nitrogen until they are ready for a patient’s use.
program is open at The University of Tennessee Medical Center.
Kelly McCaul, MD, acts as the program’s medical director and Renju V. Raj, MD, is the transplant and cellular therapy physician. “The thing that excites me the most about this is being able to bring stem cell transplants to patients in our area,” said McCaul. “This program will change the way physicians treat blood cancers and disorders in our region.” Treating Patients at One Convenient Location The state-of-the-art facility, located
Helping Blood Cancer Patients
Right Here at Home Transplant and Cellular Therapy services are now available at The University of Tennessee Medical Center
Stem Cell Transplants Help Patients With:
CAR-T Advanced Cellular Therapy Helps Patients With:
Non-Hodgkin’s Lymphoma B-Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Acute Lymphoblastic Leukemia
Leukemia Non-Hodgkin’s Lymphom a Multiple Myelom a Myelodysplastic/ a a
Myeloproliferative Disorders Certain Types of Solid Tumor Other Blood Disorders Like Aplastic Anemi a
s
s
a
6 - Cancer Institute Annual Report 2022
7
Made with FlippingBook - professional solution for displaying marketing and sales documents online